On June 14, 2017, Athenex celebrated its initial public offering (IPO) at the Nasdaq MarketSite in Times Square.
9
Active INDs
4
Technology Platforms
600
Employees
Recent News
Other Highlights
Photography by Christopher Galluzzo / Nasdaq, Inc.
Photography by Christopher Galluzzo / Nasdaq, Inc.
At the 2019 San Antonio Breast Cancer Symposium, Athenex Oncology raised awareness of chemotherapy induced peripheral neuropathy. Visitors performed everyday tasks, while wearing experiential neuropathy gloves.
Athenex is building a 409,000 square foot manufacturing facility in Dunkirk, NY, with support from New York State.
